ACES is a clinical trial sponsored by the National Heart, Lung and Blood Institute. It is being conducted in more than 25 sites with enroll 4,000 volunteer patients.
Some studies suggest that Chlamydia pneumoniae infection may be a risk factor for heart attacks and other conditions related to heart disease. This bacteria is spread person to person by sneezing and coughing (unlike a related bacteria, Chlamydia trachomatis, it is not a sexually transmitted disease). Studies show that people who have been infected with Chlamydia pneumoniae in the past have a higher chance of having a heart attack.
Anyone with a history of a heart attack, bypass surgery, angioplasty, or a 50% or greater blockage in a coronary artery is eligible for an interview for the ACES Study with their cardiologist's permission.
Call Ed Mackler, RN, at 401-793-4795, or beep him at 401-785-6331 for a phone interview.